Development and Application of Multidimensional Lipid Libraries to Investigate Lipidomic Dysregulation Related to Smoke Inhalation Injury Severity
- PMID: 34874736
- PMCID: PMC8741653
- DOI: 10.1021/acs.jproteome.1c00820
Development and Application of Multidimensional Lipid Libraries to Investigate Lipidomic Dysregulation Related to Smoke Inhalation Injury Severity
Abstract
The implication of lipid dysregulation in diseases, toxic exposure outcomes, and inflammation has brought great interest to lipidomic studies. However, lipids have proven to be analytically challenging due to their highly isomeric nature and vast concentration ranges in biological matrices. Therefore, multidimensional techniques such as those integrating liquid chromatography, ion mobility spectrometry, collision-induced dissociation, and mass spectrometry (LC-IMS-CID-MS) have been implemented to separate lipid isomers as well as provide structural information and increased identification confidence. These data sets are however extremely large and complex, resulting in challenges for data processing and annotation. Here, we have overcome these challenges by developing sample-specific multidimensional lipid libraries using the freely available software Skyline. Specifically, the human plasma library developed for this work contains over 500 unique lipids and is combined with adapted Skyline functions such as indexed retention time (iRT) for retention time prediction and IMS drift time filtering for enhanced selectivity. For comparison with other studies, this database was used to annotate LC-IMS-CID-MS data from a NIST SRM 1950 extract. The same workflow was then utilized to assess plasma and bronchoalveolar lavage fluid (BALF) samples from patients with varying degrees of smoke inhalation injury to identify lipid-based patient prognostic and diagnostic markers.
Keywords: data annotation; ion mobility spectrometry; lipidomics; smoke inhalation; spectral libraries.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- Holthuis JCM; Menon AK Lipid landscapes and pipelines in membrane homeostasis. Nature 2014, 510, 48–57. - PubMed
-
- Wenk MR The emerging field of lipidomics. Nat. Rev. Drug Discovery 2005, 4, 594–610. - PubMed
-
- Gross RW; Han X Lipidomics in Diabetes and the Metabolic Syndrome. In Lipidomics and Bioactive Lipids: Specialized Analytical Methods and Lipids in Disease; Methods in Enzymology; Elsevier, 2007; Vol. 433, pp 73–90. - PubMed
-
- Soppert J; Lehrke M; Marx N; Jankowski J; Noels H Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv. Drug Delivery Rev. 2020, 159, 4–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
